HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Endocrine Disruptor Regs In Limbo; Parliament Urges 'Suspected' Category

This article was originally published in The Rose Sheet

Executive Summary

The European Commission is mulling directives from Parliament regarding its criteria for identifying endocrine disruptors, following the latter's rejection of a related EC draft regulation in October. Among shortcomings cited by lawmakers is the absence of a "suspected" ED category, which would be "extremely relevant" in the cosmetics sector, they say.

You may also be interested in...



ECHA Launches Consumer-Facing ‘Chemicals In Our Life’ Website

Featuring a “Chemicals in Cosmetics” section and pages devoted to allergens and endocrine disruptors, the new site could draw fresh attention to ingredient hazards while also helping to dispel widely held misconceptions.

EC's Non-Automatic Ban Policy For CMRs In Cosmetics 'Plainly Illegal' – NGOs

According to the consumer umbrella organization BEUC, the European Commission changed its tune last year on whether carcinogenic, mutagenic or reprotoxic substances are automatically prohibited from use in cosmetics, taking a direction that compromises public safety and invites legal challenges. The EC maintains it has provided procedural and legal clarity while upholding the Cosmetics Regulation's general CMR ban.

EU Endocrine Disruptor Guidance Open For Comments; Benefit Cosmetics Recall; More News In Brief

A new draft guidance from the European Chemicals Agency and European Food Safety Authority could have bearing ahead on how endocrine-disrupting chemicals in cosmetic products are identified for regulatory purposes; Benefit Cosmetics recalls a line of brow gels due to contamination concerns. More news in brief.

Related Content

Topics

UsernamePublicRestriction

Register

RS121323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel